IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis

Clin Immunol. 2005 May;115(2):216-23. doi: 10.1016/j.clim.2005.01.011.

Abstract

Mastocytosis is often associated with organ involvement and hematological disorders. Patients may also exhibit elevated levels of plasma IL-6. To gain insight into the relevance of this observation, we correlated plasma levels of IL-6 and soluble IL-6 receptor (sIL-6R) with multiple disease parameters in 29 patients with mastocytosis. Mean plasma IL-6 levels were elevated in patients compared to healthy controls (P < 0.0001). Disease category significantly correlated with plasma IL-6 levels, as did severity of bone marrow pathology, organomegaly, and extent of skin involvement. In plasma, there was a positive correlation of IL-6 to total tryptase, alkaline phosphatase, IgM, white blood cell count, prothrombin time, partial thromboplastin time, and neutrophil numbers. There was an inverse correlation to hemoglobin. sIL-6R levels were not elevated. These observations demonstrate that IL-6 is a useful surrogate marker of severity of hematologic disease and suggest that IL-6 contributes to pathology.

MeSH terms

  • Adult
  • Aged
  • Bone Marrow / pathology
  • Case-Control Studies
  • Female
  • Hepatomegaly
  • Humans
  • Immunoglobulin Isotypes / blood
  • Interleukin-6 / blood*
  • Lymphatic Diseases
  • Male
  • Mastocytosis / blood*
  • Mastocytosis / pathology
  • Middle Aged
  • Receptors, Interleukin-6 / blood
  • Serine Endopeptidases / blood
  • Severity of Illness Index
  • Splenomegaly
  • Tryptases
  • Urticaria Pigmentosa / blood

Substances

  • Immunoglobulin Isotypes
  • Interleukin-6
  • Receptors, Interleukin-6
  • Serine Endopeptidases
  • Tryptases